Solid Tumors Stocks List

Solid Tumors Stocks Recent News

Date Stock Title
Jul 1 MRUS Merus names Fabian Zohren as chief medical officer
Jul 1 MRUS Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer
Jul 1 LGND Lifecore Biomedical Announces Cooperation Agreement with 22NW
Jun 28 ARGX Argenx: Strong Setup For Outperformance In 2025
Jun 27 HALO Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Jun 27 LGND Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
Jun 26 CASI CASI Pharmaceuticals jumps after receiving acquisition proposal for entire China business
Jun 26 CASI CASI Pharmaceuticals Announces Plan To Submit IND Application For CID-103, an Anti-CD 38 Antibody in Antibody-Mediated Rejection, and Receipt of a Non-Binding Proposal to Acquire Entire China Business of the Company
Jun 26 CASI CASI Pharmaceuticals Announces $15 Million Private Placement Financing by Venrock Healthcare Capital Partners, Foresite Capital, Panacea Venture and Dr. Wei-Wu He
Jun 26 ARGX Hidden Gems: Three Stocks Estimated Below Market Value in June 2024
Jun 25 ARGX argenx Highlights Breadth of Autoimmune Pipeline with New Multifocal Motor Neuropathy Data at 2024 Peripheral Nerve Society Annual Meeting
Jun 25 HALO Roche’s Ocrevus SC administration approved by European Commission
Jun 25 ARGX Argenx (ARGX) Surges 11.7%: Is This an Indication of Further Gains?
Jun 25 HALO Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
Solid Tumors

Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

Browse All Tags